VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Viral Vector & Plasmid Dna Manufacturing -Overview Global Viral Vector and Plasmid DNA Manufacturing Market, by Product Type (Viral Vector, Plasma DNA, and Non-viral DNA Vectors), by Therapeutic Application (Cancer, Inherited Disorders, Infectious Diseases, and Others), by End Product (DNA Vaccines, Gene Therapy, Immunotherapy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is expected to be valued at US$ 427.2 million in 2019, and is expected to exhibit a CAGR of 22.8% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights. The increasing incidence of HIV is expected to offer growth opportunities to industry players operating in the global market. For instance, according to the Joint United Nations Program on HIV/AIDS in 2018, over 37.9 million people were diagnosed with HIV, whereas 24.5 million people across the globe received antiretroviral therapy till June 2019. Various research institutes are focusing on the development of viral vectors and plasmid DNA, which is expected to drive the market growth over the forecast period. For instance, in October 2019, researchers at the National Institutes of Health developed a novel viral vector, which is a vehicle to deliver gene therapy to patients suffering from sickle cell anemia. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/viralvectors-and-plasmid-dna-manufacturing-market-962 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Browse 34 Market Data Tables and 33 Figures spread through 201 Pages and in-depth TOC on Viral Vector and Plasmid DNA Manufacturing Market- Global Forecast to 2027, by Product Type (Viral Vector (Retroviral Vectors, Adenoviral Vectors, Lentiviral Vectors, Adeno-associated Viral Vectors, and Others), Plasmid DNA, and Non-viral DNA Vectors), by Therapeutic Application (Cancer, Inherited Disorders, Infectious Diseases and Others), by End Product (DNA Vaccines, Gene Therapy, Immunotherapy and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Key players in the market are focused on adopting growth strategies such as mergers and acquisitions, collaborations, license agreements, and partnerships to expand their product portfolio and presence in the viral vector and plasmid DNA manufacturing market. For instance, in April 2018, Vigene Biosciences Inc. (Vigene), a biotechnology company for viral vector production and development, partnered with Virovek to utilize Vigene’s proprietary Adeno-associated Virus (AAV) Production Technology, where baculovirus (BAC) expression system is used for Adeno-associated Virus (AAV) production. Vectors produced from BACto-AAV technology can infect and transduce large number of mammalian cells in-vivo and in-vitro.
Moreover, in December 2017, Lonza, Massachusetts Eye and Ear (MEE), and Akouos, a biotechnology company, entered strategic license agreements to obtain exclusive rights to design adeno-associated viral vectors (Anc- AAV) gene therapy for hearing and balance disorder. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/962 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Global Viral Vector and Plasmid DNA Manufacturing Market: • The global viral vector and plasmid DNA manufacturing market is expected to exhibit a CAGR of 8% over the forecast period, owing to rising incidence of cancer and infectious disease. For instance, according to the National Cancer Institute (NCI) estimation, in 2018, around 1,735,350 new cases of cancer were diagnosed in the U.S. Moreover, in November 2019, the Public Health England estimated that nearly 103,800 people were living with HIV in the UK in 2018. • Among product type, the viral vector segment accounted for a significant market share in 2018, owing to increasing funding for research and development of efficient products to meet demand. For instance, in February 2018, Cobra Biologics and Symbiosis Pharmaceutical Services received a 16-month collaborative funding of US$ 2.5 Mn from Innovate UK. The fund is expected to assist Cobra Biologics and Symbiosis Pharmaceutical Services to increase their commercial viral vector manufacturing capabilities within the U.K. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/market-insight/viral-vectors-andplasmid-dna-manufacturing-market-962 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved